REPLAY: Understanding Omnipod 5: The future of Diabetes Tech

In our inaugural episode, hosts Kate Neal and Cindy Pickering are joined by Dr Sufyan Hussain, consultant in diabetes, endocrinology and general medicine at Guys and St Thomas’s Hospital in London. Dr Hussain talks about his personal and professional experience with type 1 diabetes and how he has seen technology rapidly evolve over the past decade. He discusses his work as a clinician, helping others to manage diabetes with game-changing results through Omnipod® 5 and the approach to training patients on the Omnipod® 5 System in the UK. He provides practical advice to clinicians and sets expectations for patients just starting out with the technology, and shares case studies where there has been a significant breakthrough in the management of diabetes. Recorded in March 2024. Disclaimer Note: The information in this podcast is accurate to the date of recording as of 27/03/2024. Dr. Sufyan Hussain, interviewed here, received a fee from Insulet for taking part in this podcast. Views and opinions expressed in this podcast are his own and do not necessarily reflect those of Insulet.  This Podcast is meant for healthcare professionals to better understand the Omnipod 5 System and its use within clinical practice settings. Omnipod 5 is CE Marked, UKCA marked, Health Canada approved, and TGA approved for use in Type 1 diabetes in people ages 2 years and up. For a complete description of Omnipod 5, including indications, contraindications and important safety information for the UK, please visit: https://www.omnipod.com/en-gb/safety For other regions, please refer to country-specific statements at www.omnipod.com. Omnipod 5 may not be available in your country.  ©2026 Insulet Corporation. All rights reserved. Insulet Netherlands BV, Stadsplateau 7, 3521 AZ Ultrecht, Netherlands INS-OHS-03-2026-00187 v1.0